申请人:MIRATI THERAPEUTICS INC
公开号:WO2022271679A1
公开(公告)日:2022-12-29
The present invention relates to compounds that inhibit Son of sevenless homolog 1 (SOS1) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.
本发明涉及抑制七个相似物之子1 (SOS1) 活性的化合物。具体而言,本发明涉及化合物、制药组合物和使用方法,例如使用本发明的化合物和制药组合物治疗癌症的方法。